Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients
J Infect
.
2021 Mar;82(3):414-451.
doi: 10.1016/j.jinf.2020.10.024.
Epub 2020 Oct 27.
Authors
Marco Merli
1
,
Luisa Pasulo
2
,
Giovanni Perricone
3
,
Giovanna Travi
3
,
Roberto Rossotti
3
,
Valeriana Giuseppina Colombo
3
,
Riccardo De Carlis
3
,
Stefania Chiappetta
2
,
Maria Cristina Moioli
3
,
Enrico Minetti
3
,
Maria Frigerio
3
,
Luciano Gregorio De Carlis
3
,
Luca Belli
3
,
Stefano Fagiuoli
3
,
Massimo Puoti
3
Affiliations
1
ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy. Electronic address:
[email protected]
.
2
Division of Gastroenterology, Hepatology and Transplantation, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy.
3
ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
PMID:
33127455
PMCID:
PMC7590634
DOI:
10.1016/j.jinf.2020.10.024
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
COVID-19*
Child
Humans
Immunosuppression Therapy / adverse effects
Immunosuppressive Agents / adverse effects
SARS-CoV-2*
Transplant Recipients
Substances
Immunosuppressive Agents